Singapore markets open in 7 hours 20 minutes

Abrdn Life Sciences Investors (HQL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.25-0.19 (-1.41%)
As of 01:40PM EDT. Market open.

Abrdn Life Sciences Investors

1900 Market Street
Suite 200
Philadelphia, PA 19103
United States
215 405 5700

Sector(s)Financial Services
IndustryAsset Management
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Daniel R. Omstead M.S, Ph.D.Principal Executive Officer, President and TrusteeN/AN/A1953
Mr. Peter BrannerChief Investment OfficerN/AN/AN/A
Amounts are as of 31 December 2013, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Corporate governance

Abrdn Life Sciences Investors’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.